▶ 調査レポート

小児科用抗てんかん薬の世界市場 2020年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global Anti-epileptic Drugs for Pediatrics Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。小児科用抗てんかん薬の世界市場 2020年:メーカー別、地域別、種類・用途別 / Global Anti-epileptic Drugs for Pediatrics Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / D005-01881資料のイメージです。• レポートコード:D005-01881
• 出版社/出版日:GlobalInfoResearch / 2020年5月
• レポート形態:英文、PDF、105ページ
• 納品方法:Eメール(納期2~3日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥379,320 (USD3,480)▷ お問い合わせ
  Multi User¥568,980 (USD5,220)▷ お問い合わせ
  Corporate User¥758,640 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、小児科用抗てんかん薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。小児科用抗てんかん薬の種類別市場規模(1世代、2世代、3世代)、用途別市場規模(病院、小売薬局、オンライン薬局)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Mylan N.V、UCB Pharma Limited、Janssen Pharmaceuticals、Cephalon, Inc、Sanofi S.A、GlaxoSmithKline plc、Valeant Pharmaceuticals International, Inc、Pfizer, Inc、Novartis AG、Sunovion Pharmaceuticals Limited、Zogenix、Zynerba、GW Pharmaceuticals、Insys
・地域別グローバル市場分析 2015年-2020年
・小児科用抗てんかん薬の北米市場(アメリカ、カナダ、メキシコ)
・小児科用抗てんかん薬のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・小児科用抗てんかん薬のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・小児科用抗てんかん薬の南米市場(ブラジル、アルゼンチン)
・小児科用抗てんかん薬の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:1世代、2世代、3世代
・用途別分析:病院、小売薬局、オンライン薬局
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global Anti-epileptic Drugs for Pediatrics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.3% in the forecast period of 2020 to 2025 and will expected to reach USD 839.2 million by 2025, from USD 709.5 million in 2019.

The Anti-epileptic Drugs for Pediatrics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Anti-epileptic Drugs for Pediatrics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Anti-epileptic Drugs for Pediatrics market has been segmented into
1st generation
2nd generation
3rd generation

By Application, Anti-epileptic Drugs for Pediatrics has been segmented into:
Hospitals
Retail pharmacies
Online pharmacies

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Anti-epileptic Drugs for Pediatrics market presented in the report. This section sheds light on the sales growth of different regional and country-level Anti-epileptic Drugs for Pediatrics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Anti-epileptic Drugs for Pediatrics market.

The report offers in-depth assessment of the growth and other aspects of the Anti-epileptic Drugs for Pediatrics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Anti-epileptic Drugs for Pediatrics Market Share Analysis
Anti-epileptic Drugs for Pediatrics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Anti-epileptic Drugs for Pediatrics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Anti-epileptic Drugs for Pediatrics sales, revenue and market share for each player covered in this report.

The major players covered in Anti-epileptic Drugs for Pediatrics are:
Mylan N.V
UCB Pharma Limited
Janssen Pharmaceuticals
Cephalon, Inc
Sanofi S.A
GlaxoSmithKline plc
Valeant Pharmaceuticals International, Inc
Pfizer, Inc
Novartis AG
Sunovion Pharmaceuticals Limited
Zogenix
Zynerba
GW Pharmaceuticals
Insys

Among other players domestic and global, Anti-epileptic Drugs for Pediatrics market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti-epileptic Drugs for Pediatrics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anti-epileptic Drugs for Pediatrics, with price, sales, revenue and global market share of Anti-epileptic Drugs for Pediatrics in 2018 and 2019.
Chapter 3, the Anti-epileptic Drugs for Pediatrics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-epileptic Drugs for Pediatrics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Anti-epileptic Drugs for Pediatrics market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Anti-epileptic Drugs for Pediatrics sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

Table of Contents

1 Market Overview
1.1 Anti-epileptic Drugs for Pediatrics Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anti-epileptic Drugs for Pediatrics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 1st generation
1.2.3 2nd generation
1.2.4 3rd generation
1.3 Market Analysis by Application
1.3.1 Overview: Global Anti-epileptic Drugs for Pediatrics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Retail pharmacies
1.3.4 Online pharmacies
1.4 Overview of Global Anti-epileptic Drugs for Pediatrics Market
1.4.1 Global Anti-epileptic Drugs for Pediatrics Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Mylan N.V
2.1.1 Mylan N.V Details
2.1.2 Mylan N.V Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Mylan N.V SWOT Analysis
2.1.4 Mylan N.V Product and Services
2.1.5 Mylan N.V Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 UCB Pharma Limited
2.2.1 UCB Pharma Limited Details
2.2.2 UCB Pharma Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 UCB Pharma Limited SWOT Analysis
2.2.4 UCB Pharma Limited Product and Services
2.2.5 UCB Pharma Limited Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Janssen Pharmaceuticals
2.3.1 Janssen Pharmaceuticals Details
2.3.2 Janssen Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Janssen Pharmaceuticals SWOT Analysis
2.3.4 Janssen Pharmaceuticals Product and Services
2.3.5 Janssen Pharmaceuticals Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Cephalon, Inc
2.4.1 Cephalon, Inc Details
2.4.2 Cephalon, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Cephalon, Inc SWOT Analysis
2.4.4 Cephalon, Inc Product and Services
2.4.5 Cephalon, Inc Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sanofi S.A
2.5.1 Sanofi S.A Details
2.5.2 Sanofi S.A Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sanofi S.A SWOT Analysis
2.5.4 Sanofi S.A Product and Services
2.5.5 Sanofi S.A Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 GlaxoSmithKline plc
2.6.1 GlaxoSmithKline plc Details
2.6.2 GlaxoSmithKline plc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 GlaxoSmithKline plc SWOT Analysis
2.6.4 GlaxoSmithKline plc Product and Services
2.6.5 GlaxoSmithKline plc Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Valeant Pharmaceuticals International, Inc
2.7.1 Valeant Pharmaceuticals International, Inc Details
2.7.2 Valeant Pharmaceuticals International, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Valeant Pharmaceuticals International, Inc SWOT Analysis
2.7.4 Valeant Pharmaceuticals International, Inc Product and Services
2.7.5 Valeant Pharmaceuticals International, Inc Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Pfizer, Inc
2.8.1 Pfizer, Inc Details
2.8.2 Pfizer, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Pfizer, Inc SWOT Analysis
2.8.4 Pfizer, Inc Product and Services
2.8.5 Pfizer, Inc Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Novartis AG
2.9.1 Novartis AG Details
2.9.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Novartis AG SWOT Analysis
2.9.4 Novartis AG Product and Services
2.9.5 Novartis AG Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Sunovion Pharmaceuticals Limited
2.10.1 Sunovion Pharmaceuticals Limited Details
2.10.2 Sunovion Pharmaceuticals Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Sunovion Pharmaceuticals Limited SWOT Analysis
2.10.4 Sunovion Pharmaceuticals Limited Product and Services
2.10.5 Sunovion Pharmaceuticals Limited Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Zogenix
2.11.1 Zogenix Details
2.11.2 Zogenix Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Zogenix SWOT Analysis
2.11.4 Zogenix Product and Services
2.11.5 Zogenix Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Zynerba
2.12.1 Zynerba Details
2.12.2 Zynerba Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Zynerba SWOT Analysis
2.12.4 Zynerba Product and Services
2.12.5 Zynerba Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 GW Pharmaceuticals
2.13.1 GW Pharmaceuticals Details
2.13.2 GW Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 GW Pharmaceuticals SWOT Analysis
2.13.4 GW Pharmaceuticals Product and Services
2.13.5 GW Pharmaceuticals Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Insys
2.14.1 Insys Details
2.14.2 Insys Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Insys SWOT Analysis
2.14.4 Insys Product and Services
2.14.5 Insys Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Anti-epileptic Drugs for Pediatrics Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Anti-epileptic Drugs for Pediatrics Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Anti-epileptic Drugs for Pediatrics Manufacturer Market Share in 2019
3.3.2 Top 6 Anti-epileptic Drugs for Pediatrics Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Anti-epileptic Drugs for Pediatrics Sales, Revenue and Market Share by Regions
4.1.1 Global Anti-epileptic Drugs for Pediatrics Sales and Market Share by Regions (2015-2020)
4.1.2 Global Anti-epileptic Drugs for Pediatrics Revenue and Market Share by Regions (2015-2020)
4.2 North America Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020)
4.3 Europe Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020)
4.5 South America Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Anti-epileptic Drugs for Pediatrics Sales, Revenue and Market Share by Country
5.1.1 North America Anti-epileptic Drugs for Pediatrics Sales and Market Share by Country (2015-2020)
5.1.2 North America Anti-epileptic Drugs for Pediatrics Revenue and Market Share by Country (2015-2020)
5.2 United States Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020)
5.3 Canada Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020)
5.4 Mexico Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Anti-epileptic Drugs for Pediatrics Sales, Revenue and Market Share by Country
6.1.1 Europe Anti-epileptic Drugs for Pediatrics Sales and Market Share by Country (2015-2020)
6.1.2 Europe Anti-epileptic Drugs for Pediatrics Revenue and Market Share by Country (2015-2020)
6.2 Germany Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020)
6.3 UK Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020)
6.4 France Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020)
6.5 Russia Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020)
6.6 Italy Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Anti-epileptic Drugs for Pediatrics Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Anti-epileptic Drugs for Pediatrics Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Anti-epileptic Drugs for Pediatrics Revenue and Market Share by Regions (2015-2020)
7.2 China Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020)
7.3 Japan Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020)
7.4 Korea Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020)
7.5 India Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020)
7.7 Australia Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Anti-epileptic Drugs for Pediatrics Sales, Revenue and Market Share by Country
8.1.1 South America Anti-epileptic Drugs for Pediatrics Sales and Market Share by Country (2015-2020)
8.1.2 South America Anti-epileptic Drugs for Pediatrics Revenue and Market Share by Country (2015-2020)
8.2 Brazil Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020)
8.3 Argentina Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Anti-epileptic Drugs for Pediatrics Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Anti-epileptic Drugs for Pediatrics Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Anti-epileptic Drugs for Pediatrics Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020)
9.3 Turkey Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020)
9.4 Egypt Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020)
9.5 South Africa Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Anti-epileptic Drugs for Pediatrics Sales and Market Share by Type (2015-2020)
10.2 Global Anti-epileptic Drugs for Pediatrics Revenue and Market Share by Type (2015-2020)
10.3 Global Anti-epileptic Drugs for Pediatrics Price by Type (2015-2020)
11 Global Anti-epileptic Drugs for Pediatrics Market Segment by Application
11.1 Global Anti-epileptic Drugs for Pediatrics Sales Market Share by Application (2015-2020)
11.2 Global Anti-epileptic Drugs for Pediatrics Revenue Market Share by Application (2015-2020)
11.3 Global Anti-epileptic Drugs for Pediatrics Price by Application (2015-2020)
12 Market Forecast
12.1 Global Anti-epileptic Drugs for Pediatrics Sales, Revenue and Growth Rate (2021-2025)
12.2 Anti-epileptic Drugs for Pediatrics Market Forecast by Regions (2021-2025)
12.2.1 North America Anti-epileptic Drugs for Pediatrics Market Forecast (2021-2025)
12.2.2 Europe Anti-epileptic Drugs for Pediatrics Market Forecast (2021-2025)
12.2.3 Asia-Pacific Anti-epileptic Drugs for Pediatrics Market Forecast (2021-2025)
12.2.4 South America Anti-epileptic Drugs for Pediatrics Market Forecast (2021-2025)
12.2.5 Middle East & Africa Anti-epileptic Drugs for Pediatrics Market Forecast (2021-2025)
12.3 Anti-epileptic Drugs for Pediatrics Market Forecast by Type (2021-2025)
12.3.1 Global Anti-epileptic Drugs for Pediatrics Sales Forecast by Type (2021-2025)
12.3.2 Global Anti-epileptic Drugs for Pediatrics Market Share Forecast by Type (2021-2025)
12.4 Anti-epileptic Drugs for Pediatrics Market Forecast by Application (2021-2025)
12.4.1 Global Anti-epileptic Drugs for Pediatrics Sales Forecast by Application (2021-2025)
12.4.2 Global Anti-epileptic Drugs for Pediatrics Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Anti-epileptic Drugs for Pediatrics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Anti-epileptic Drugs for Pediatrics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Anti-epileptic Drugs for Pediatrics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Mylan N.V Basic Information, Manufacturing Base and Competitors
Table 8. Mylan N.V Anti-epileptic Drugs for Pediatrics Major Business
Table 9. Mylan N.V Anti-epileptic Drugs for Pediatrics Total Revenue (USD Million) (2017-2018)
Table 10. Mylan N.V SWOT Analysis
Table 11. Mylan N.V Anti-epileptic Drugs for Pediatrics Product and Services
Table 12. Mylan N.V Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. UCB Pharma Limited Basic Information, Manufacturing Base and Competitors
Table 14. UCB Pharma Limited Anti-epileptic Drugs for Pediatrics Major Business
Table 15. UCB Pharma Limited Anti-epileptic Drugs for Pediatrics Total Revenue (USD Million) (2017-2018)
Table 16. UCB Pharma Limited SWOT Analysis
Table 17. UCB Pharma Limited Anti-epileptic Drugs for Pediatrics Product and Services
Table 18. UCB Pharma Limited Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Janssen Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Janssen Pharmaceuticals Anti-epileptic Drugs for Pediatrics Major Business
Table 21. Janssen Pharmaceuticals Anti-epileptic Drugs for Pediatrics Total Revenue (USD Million) (2017-2018)
Table 22. Janssen Pharmaceuticals SWOT Analysis
Table 23. Janssen Pharmaceuticals Anti-epileptic Drugs for Pediatrics Product and Services
Table 24. Janssen Pharmaceuticals Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Cephalon, Inc Basic Information, Manufacturing Base and Competitors
Table 26. Cephalon, Inc Anti-epileptic Drugs for Pediatrics Major Business
Table 27. Cephalon, Inc Anti-epileptic Drugs for Pediatrics Total Revenue (USD Million) (2017-2018)
Table 28. Cephalon, Inc SWOT Analysis
Table 29. Cephalon, Inc Anti-epileptic Drugs for Pediatrics Product and Services
Table 30. Cephalon, Inc Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Sanofi S.A Basic Information, Manufacturing Base and Competitors
Table 32. Sanofi S.A Anti-epileptic Drugs for Pediatrics Major Business
Table 33. Sanofi S.A Anti-epileptic Drugs for Pediatrics Total Revenue (USD Million) (2017-2018)
Table 34. Sanofi S.A SWOT Analysis
Table 35. Sanofi S.A Anti-epileptic Drugs for Pediatrics Product and Services
Table 36. Sanofi S.A Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 38. GlaxoSmithKline plc Anti-epileptic Drugs for Pediatrics Major Business
Table 39. GlaxoSmithKline plc Anti-epileptic Drugs for Pediatrics Total Revenue (USD Million) (2017-2018)
Table 40. GlaxoSmithKline plc SWOT Analysis
Table 41. GlaxoSmithKline plc Anti-epileptic Drugs for Pediatrics Product and Services
Table 42. GlaxoSmithKline plc Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Valeant Pharmaceuticals International, Inc Basic Information, Manufacturing Base and Competitors
Table 44. Valeant Pharmaceuticals International, Inc Anti-epileptic Drugs for Pediatrics Major Business
Table 45. Valeant Pharmaceuticals International, Inc Anti-epileptic Drugs for Pediatrics Total Revenue (USD Million) (2017-2018)
Table 46. Valeant Pharmaceuticals International, Inc SWOT Analysis
Table 47. Valeant Pharmaceuticals International, Inc Anti-epileptic Drugs for Pediatrics Product and Services
Table 48. Valeant Pharmaceuticals International, Inc Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Pfizer, Inc Basic Information, Manufacturing Base and Competitors
Table 50. Pfizer, Inc Anti-epileptic Drugs for Pediatrics Major Business
Table 51. Pfizer, Inc Anti-epileptic Drugs for Pediatrics Total Revenue (USD Million) (2017-2018)
Table 52. Pfizer, Inc SWOT Analysis
Table 53. Pfizer, Inc Anti-epileptic Drugs for Pediatrics Product and Services
Table 54. Pfizer, Inc Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 56. Novartis AG Anti-epileptic Drugs for Pediatrics Major Business
Table 57. Novartis AG Anti-epileptic Drugs for Pediatrics Total Revenue (USD Million) (2017-2018)
Table 58. Novartis AG SWOT Analysis
Table 59. Novartis AG Anti-epileptic Drugs for Pediatrics Product and Services
Table 60. Novartis AG Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Sunovion Pharmaceuticals Limited Basic Information, Manufacturing Base and Competitors
Table 62. Sunovion Pharmaceuticals Limited Anti-epileptic Drugs for Pediatrics Major Business
Table 63. Sunovion Pharmaceuticals Limited Anti-epileptic Drugs for Pediatrics Total Revenue (USD Million) (2017-2018)
Table 64. Sunovion Pharmaceuticals Limited SWOT Analysis
Table 65. Sunovion Pharmaceuticals Limited Anti-epileptic Drugs for Pediatrics Product and Services
Table 66. Sunovion Pharmaceuticals Limited Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Zogenix Basic Information, Manufacturing Base and Competitors
Table 68. Zogenix Anti-epileptic Drugs for Pediatrics Major Business
Table 69. Zogenix Anti-epileptic Drugs for Pediatrics Total Revenue (USD Million) (2017-2018)
Table 70. Zogenix SWOT Analysis
Table 71. Zogenix Anti-epileptic Drugs for Pediatrics Product and Services
Table 72. Zogenix Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Zynerba Basic Information, Manufacturing Base and Competitors
Table 74. Zynerba Anti-epileptic Drugs for Pediatrics Major Business
Table 75. Zynerba Anti-epileptic Drugs for Pediatrics Total Revenue (USD Million) (2017-2018)
Table 76. Zynerba SWOT Analysis
Table 77. Zynerba Anti-epileptic Drugs for Pediatrics Product and Services
Table 78. Zynerba Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. GW Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 80. GW Pharmaceuticals Anti-epileptic Drugs for Pediatrics Major Business
Table 81. GW Pharmaceuticals Anti-epileptic Drugs for Pediatrics Total Revenue (USD Million) (2017-2018)
Table 82. GW Pharmaceuticals SWOT Analysis
Table 83. GW Pharmaceuticals Anti-epileptic Drugs for Pediatrics Product and Services
Table 84. GW Pharmaceuticals Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Insys Basic Information, Manufacturing Base and Competitors
Table 86. Insys Anti-epileptic Drugs for Pediatrics Major Business
Table 87. Insys Anti-epileptic Drugs for Pediatrics Total Revenue (USD Million) (2017-2018)
Table 88. Insys SWOT Analysis
Table 89. Insys Anti-epileptic Drugs for Pediatrics Product and Services
Table 90. Insys Anti-epileptic Drugs for Pediatrics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Global Anti-epileptic Drugs for Pediatrics Sales by Manufacturer (2018-2019) (K Units)
Table 92. Global Anti-epileptic Drugs for Pediatrics Revenue by Manufacturer (2018-2019) (USD Million)
Table 93. Global Anti-epileptic Drugs for Pediatrics Sales by Regions (2015-2020) (K Units)
Table 94. Global Anti-epileptic Drugs for Pediatrics Sales Market Share by Regions (2015-2020)
Table 95. Global Anti-epileptic Drugs for Pediatrics Revenue by Regions (2015-2020) (USD Million)
Table 96. North America Anti-epileptic Drugs for Pediatrics Sales by Countries (2015-2020) (K Units)
Table 97. North America Anti-epileptic Drugs for Pediatrics Sales Market Share by Countries (2015-2020)
Table 98. North America Anti-epileptic Drugs for Pediatrics Revenue by Countries (2015-2020) (USD Million)
Table 99. North America Anti-epileptic Drugs for Pediatrics Revenue Market Share by Countries (2015-2020)
Table 100. Europe Anti-epileptic Drugs for Pediatrics Sales by Countries (2015-2020) (K Units)
Table 101. Europe Anti-epileptic Drugs for Pediatrics Sales Market Share by Countries (2015-2020)
Table 102. Europe Anti-epileptic Drugs for Pediatrics Revenue by Countries (2015-2020) (USD Million)
Table 103. Asia-Pacific Anti-epileptic Drugs for Pediatrics Sales by Regions (2015-2020) (K Units)
Table 104. Asia-Pacific Anti-epileptic Drugs for Pediatrics Sales Market Share by Regions (2015-2020)
Table 105. Asia-Pacific Anti-epileptic Drugs for Pediatrics Revenue by Regions (2015-2020) (USD Million)
Table 106. South America Anti-epileptic Drugs for Pediatrics Sales by Countries (2015-2020) (K Units)
Table 107. South America Anti-epileptic Drugs for Pediatrics Sales Market Share by Countries (2015-2020)
Table 108. South America Anti-epileptic Drugs for Pediatrics Revenue by Countries (2015-2020) (USD Million)
Table 109. South America Anti-epileptic Drugs for Pediatrics Revenue Market Share by Countries (2015-2020)
Table 110. Middle East & Africa Anti-epileptic Drugs for Pediatrics Sales by Countries (2015-2020) (K Units)
Table 111. Middle East & Africa Anti-epileptic Drugs for Pediatrics Sales Market Share by Countries (2015-2020)
Table 112. Middle East & Africa Anti-epileptic Drugs for Pediatrics Revenue by Countries (2015-2020) (USD Million)
Table 113. Middle East & Africa Anti-epileptic Drugs for Pediatrics Revenue Market Share by Countries (2015-2020)
Table 114. Global Anti-epileptic Drugs for Pediatrics Sales by Type (2015-2020) (K Units)
Table 115. Global Anti-epileptic Drugs for Pediatrics Sales Share by Type (2015-2020)
Table 116. Global Anti-epileptic Drugs for Pediatrics Revenue by Type (2015-2020) (USD Million)
Table 117. Global Anti-epileptic Drugs for Pediatrics Revenue Share by Type (2015-2020)
Table 118. Global Anti-epileptic Drugs for Pediatrics Sales by Application (2015-2020) (K Units)
Table 119. Global Anti-epileptic Drugs for Pediatrics Sales Share by Application (2015-2020)
Table 120. Global Anti-epileptic Drugs for Pediatrics Sales Forecast by Regions (2021-2025) (K Units)
Table 121. Global Anti-epileptic Drugs for Pediatrics Market Share Forecast by Regions (2021-2025)
Table 122. Global Anti-epileptic Drugs for Pediatrics Sales Forecast by Type (2021-2025) (K Units)
Table 123. Global Anti-epileptic Drugs for Pediatrics Market Share Forecast by Type (2021-2025)
Table 124. Global Anti-epileptic Drugs for Pediatrics Sales Forecast by Application (2021-2025)
Table 125. Global Anti-epileptic Drugs for Pediatrics Market Share Forecast by Application (2021-2025)
Table 126. Direct Channel Pros & Cons
Table 127. Indirect Channel Pros & Cons
Table 128. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Anti-epileptic Drugs for Pediatrics Picture
Figure 2. Global Sales Market Share of Anti-epileptic Drugs for Pediatrics by Type in 2019
Figure 3. 1st generation Picture
Figure 4. 2nd generation Picture
Figure 5. 3rd generation Picture
Figure 6. Anti-epileptic Drugs for Pediatrics Sales Market Share by Application in 2018
Figure 7. Hospitals Picture
Figure 8. Retail pharmacies Picture
Figure 9. Online pharmacies Picture
Figure 10. Global Anti-epileptic Drugs for Pediatrics Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Anti-epileptic Drugs for Pediatrics Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Anti-epileptic Drugs for Pediatrics Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Anti-epileptic Drugs for Pediatrics Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Anti-epileptic Drugs for Pediatrics Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Anti-epileptic Drugs for Pediatrics Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Anti-epileptic Drugs for Pediatrics Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Anti-epileptic Drugs for Pediatrics Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Anti-epileptic Drugs for Pediatrics Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Anti-epileptic Drugs for Pediatrics Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Anti-epileptic Drugs for Pediatrics Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Anti-epileptic Drugs for Pediatrics Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Anti-epileptic Drugs for Pediatrics Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Anti-epileptic Drugs for Pediatrics Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Anti-epileptic Drugs for Pediatrics Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Anti-epileptic Drugs for Pediatrics Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Anti-epileptic Drugs for Pediatrics Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Anti-epileptic Drugs for Pediatrics Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Anti-epileptic Drugs for Pediatrics Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Anti-epileptic Drugs for Pediatrics Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Anti-epileptic Drugs for Pediatrics Sales Market Share by Manufacturer in 2019
Figure 31. Global Anti-epileptic Drugs for Pediatrics Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Anti-epileptic Drugs for Pediatrics Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Anti-epileptic Drugs for Pediatrics Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020) (K Units)
Figure 36. Global Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Anti-epileptic Drugs for Pediatrics Revenue Market Share by Regions (2015-2020)
Figure 38. Global Anti-epileptic Drugs for Pediatrics Revenue Market Share by Regions in 2018
Figure 39. North America Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020)
Figure 40. Europe Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020)
Figure 42. South America Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020)
Figure 44. North America Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Anti-epileptic Drugs for Pediatrics Sales Market Share by Countries (2015-2020)
Figure 46. North America Anti-epileptic Drugs for Pediatrics Sales Market Share by Countries in 2018
Figure 47. North America Anti-epileptic Drugs for Pediatrics Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Anti-epileptic Drugs for Pediatrics Revenue Market Share by Countries in 2018
Figure 49. United States Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Canada Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Mexico Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Europe Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Anti-epileptic Drugs for Pediatrics Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Anti-epileptic Drugs for Pediatrics Revenue Market Share by Countries in 2019
Figure 55. Germany Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020) (K Units)
Figure 56. UK Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020) (K Units)
Figure 57. France Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Russia Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Italy Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Asia-Pacific Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Anti-epileptic Drugs for Pediatrics Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Anti-epileptic Drugs for Pediatrics Revenue Market Share by Regions 2019
Figure 63. China Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Japan Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Korea Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020) (K Units)
Figure 66. India Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Southeast Asia Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020) (K Units)
Figure 68. South America Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Anti-epileptic Drugs for Pediatrics Sales Market Share by Countries in 2019
Figure 70. South America Anti-epileptic Drugs for Pediatrics Revenue Market Share by Countries in 2019
Figure 71. Brazil Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Argentina Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Middle East and Africa Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Anti-epileptic Drugs for Pediatrics Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Anti-epileptic Drugs for Pediatrics Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Anti-epileptic Drugs for Pediatrics Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Egypt Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Turkey Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020) (K Units)
Figure 80. South Africa Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Global Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2021-2025) (K Units)
Figure 82. Global Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Anti-epileptic Drugs for Pediatrics Market Forecast (2021-2025) (K Units)
Figure 84. Europe Sales Anti-epileptic Drugs for Pediatrics Market Forecast (2021-2025) (K Units)
Figure 85. Asia-Pacific Sales Anti-epileptic Drugs for Pediatrics Market Forecast (2021-2025) (K Units)
Figure 86. South America Sales Anti-epileptic Drugs for Pediatrics Market Forecast (2021-2025) (K Units)
Figure 87. Middle East & Africa Sales Anti-epileptic Drugs for Pediatrics Market Forecast (2021-2025) (K Units)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel